Enhancing Cell Nucleus Accumulation and DNA Cleavage Activity of Anti-Cancer Drug via Graphene Quantum Dots
Open Access
- 4 October 2013
- journal article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 3 (1), 2852
- https://doi.org/10.1038/srep02852
Abstract
Graphene quantum dots (GQDs) maintain the intrinsic layered structural motif of graphene but with smaller lateral size and abundant periphery carboxylic groups, and are more compatible with biological system, thus are promising nanomaterials for therapeutic applications. Here we show that GQDs have a superb ability in drug delivery and anti-cancer activity boost without any pre-modification due to their unique structural properties. They could efficiently deliver doxorubicin (DOX) to the nucleus through DOX/GQD conjugates, because the conjugates assume different cellular and nuclear internalization pathways comparing to free DOX. Also, the conjugates could enhance DNA cleavage activity of DOX markedly. This enhancement combining with efficient nuclear delivery improved cytotoxicity of DOX dramatically. Furthermore, the DOX/GQD conjugates could also increase the nuclear uptake and cytotoxicity of DOX to drug-resistant cancer cells indicating that the conjugates may be capable to increase chemotherapy efficacy of anti-cancer drugs that are suboptimal due to the drug resistance.This publication has 51 references indexed in Scilit:
- Amphiphilic Homopolymer Vesicles as Unique Nano-Carriers for Cancer TherapyMacromolecules, 2012
- Size-Dependent Cell Uptake of Protein-Coated Graphene Oxide NanosheetsACS Applied Materials & Interfaces, 2012
- Estrogen-Anchored pH-Sensitive Liposomes as Nanomodule Designed for Site-Specific Delivery of Doxorubicin in Breast Cancer TherapyMolecular Pharmaceutics, 2011
- Catechol Polymers for pH-Responsive, Targeted Drug Delivery to Cancer CellsJournal of the American Chemical Society, 2011
- Folic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic TherapyTheranostics, 2011
- Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in CancerOnline Journal of Public Health Informatics, 2010
- Nano-graphene oxide for cellular imaging and drug deliveryNano Research, 2008
- PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer DrugsJournal of the American Chemical Society, 2008
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agentsBiochemical and Biophysical Research Communications, 1977